Skip to main content
Clinical Trials/ACTRN12620000027910
ACTRN12620000027910
Not yet recruiting
未知

In patients with type 2 diabetes, is a stepped care approach more effective than control group to achieve a clinically meaningful improvement in weight loss and glucose levels.

The University of Queensland0 sites80 target enrollmentJanuary 17, 2020

Overview

Phase
未知
Intervention
Not specified
Conditions
type 2 diabetes
Sponsor
The University of Queensland
Enrollment
80
Status
Not yet recruiting
Last Updated
6 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
January 17, 2020
End Date
TBD
Last Updated
6 years ago
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Confirmed T2D (HbA1 c greater than or equal to 6\.5%) and central obesity (waist circumference greater than or equal to 80cm for women and greater than or equal to 94cm for men).

Exclusion Criteria

  • Active individuals (i.e. meeting current activity guidelines), participants for whom a physician deems that exercise is contraindicated, unstable coronary artery disease, myocardial infarction within 6 months, uncontrolled hypertension (systolic blood pressure \>160mmHg and/or diastolic blood pressure \>90mmHg), uncontrolled cardiac or metabolic disease, alcoholic liver disease, viral hepatitis, cirrhosis, significant neurological, cognitive, back or lower limb impairment, significant musculoskeletal conditions, on insulin therapy or recent change in hypoglycaemic medication (past 3 months), pregnancy.

Outcomes

Primary Outcomes

Not specified

Similar Trials